The present study was designed to determine whether there is one or more than one critical lesion, induced by a carcinogen, relevant for initiation. The experimental approach consisted of administering a non-necrogenic dose of the carcinogen 1,2-dimethylhydrazine 2HCI (100 mg/kg, i.p.) to male Fischer 344 rats (120-140 g) and completing the initiation process by two different methods: (i) induction of liver cell proliferation by partial hepatectomy, or (ii) creation of hypornethylation in DNA by giving 5-azacytidine, an agent that inhibits DNA methylation. The initiated hepatocytes were assayed as 7-glutamyltransferase positive foci. The rationale for the approach was based on the premise that the two methods used for completing the initiation step might give either the same or a different pattern in the incidence of initiated hepatocytes depending on whether one o r more than one lesion was important for initiation, particularly if some of the lesions were allowed to repair before applying the cell proliferative stimulus or administering the 5-azacytidine. The results obtained indicated that 5;azacytidine facilitated the induction of the same number of foci whether given 12 or 96 hours after the carcinogen indicating that the critical lesion involved in this mode of initiation persisted up to at least 96 hours. In contrast, our earlier results showed that there was a reduction in the number of yglutamyltransferase positive foci when partial hepatectomy was delayed beyond 24 hours after the carcinogen administration, indicating that the critical lesion involved in this mode of initiation has a half-life of not more than 24 hours. The results of these two sets of experiments taken together indicate that carcinogens induce more than one critical lesion and the importance of the lesion might depend on the mode by which initiation is completed.
INTRODUCTION
Chemical carcinogens after appropriate aCtivation induce several types of chemi&l and/or physical lesions in DNA either di-' rectly or indirectly (1) . Replication of DNA with the critical lesions is considered important for initiation of the carcinogenic process Presented at the Second International Symposium Sponsored by the Universities of Sassari and Cagliari. Session 111: 'hletabolism of Chemical Carcinogens and Scqucntial Analysis", October [12] [13] [14] [15] 1903 . Alghero. Italy.
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( Fig. 1) (2) (3) (4) (5) . Although several of these lesions are considered critical ( 6 4 , their importance could not be established with any degree of accuracy largely because the biological end point used in these studies was cancer. Since carcinogenesis is a multistage process and several of the steps, especially the rate limiting ones, have not yet been identified, the relevance of the. carcinogeninduced lesions in the carcinogenic process has remained speculative. Using recently developed models to study the initiation and promotion phases of liver carcinogenesis we 79 
FIG. 1-Schematic representation showing the role of cell proliferation in the initiation phase of an initiation-promotion model for experimental liver carcinogenesis.
obtained evidence, albeit indirect, to indicate that there may be at least two critical lesions; a primary lesion responsible for initiation, and a group of secondary ones which confer a property by virtue of which the initiated hepatocytes can be promoted by different promoting regimens (10, 11) . During our attempts to identify the primary lesions, it became important to determine whether one or more than one of the lesions induced by the carcinogen are important for initiation. With this in view we have been developing experimental models wherein initiation depends not only on the administered carcinogen but also on sonie. other exogenous manipulation subsequent to the carcinogen treatment.
In our earlier studies we observed that when a non-necrogenic dose of the carcinogen was administered incidence of initiated hepatocytes depended on supplying an exogenous liver cell proliferative stimulus (2) (3) (4) (5) . Recently, we developed another model wherein the incidence of initiated hepatocytes depended on the administration of 5azncytidine (5-AzC), an agent known to induce undermethylated DNA, following carcinogen treatment. By studying the effect of varying the interval between the administration of the carcinogen and the second m,anipulation, be it liver cell proliferative stimulus or 5-AzC, on the incidence of initiated hepatocytes one can assess the nature of the carcinogen-induced lesions that are or are not relevant for initiation. The rationale behind the approach is that the longer the interval between the administration of the carcinogen and the second manipulation, the greater will be the repair of the critical lesion and the fewer should be the number of initiated hep-atocytes formed. Using such a strategy and the two models mentioned above, we observed that carcinogens may induce more than one critical lesion and the critical nature of the lesion may depend on whether the administration of the carcinogen is followed by a liver cell proliferative stimulus or 5-AzC.
M E T t i 0 D S
Male Fischer 344 rats weighing 120 to 140 g were maintained on Purina rodent laboratory chow diet No. 5001, and on daily cycles of alternating 12 hr periods of light and darkness for one week before the start of the experiment. A semisynthetic high protein diet (No. 101) containing 0.02% 2-acetyl aminofluorene was obtained from Dyets Inc. Bethlehem, PA. 1.2-dime t hyl h ydrazine (I& DMH.2HCl) was obtained from Aldrich Chemical Co., Milwaukee, Wis. and 5-AzC from Sigma Chemical Co., St. Louis, Mo.
Influence of 5-AZc on the Induction of yglutamyltransferase (y-GT) Positive Foci by 1,2-DMH. Rats were given 1,2-DMH.2HCl (100 mg/kg, i.p.) in 0.9% NaCl solution containing ethylenediaminetetraacetate (15 mg/ 100 ml) pH 6.7, or an equivalent volume of this vehicle. Twelve hours later, a time point at which the circulating carcinogen is no longer detectable (12, 13) the rats were given 5-AzC (10 mg/kg, i.p.) or an equivaIent voIume of 0.9% NaCl solution. Another group of rats were subjected to partial hepatectomy. Two weeks later the initiated hepatocytes formed were assayed as y G T positive foci by exposing the rats to a selection regimen as described by Cayama et a1 (4).
Effect of Administration of 5-AzC Following Partial I-iepafecfomy on the Induction ofr-GT Positive Foci. Rats were partially hepatectomized and 18 or 48 hours later they were given 5-AzC (10 mg/kg, i.p.). or an equivalent volume of 0.9% NaCl. The initiated hepatocytes formed were assayed as described above. Effect of 5-AzC Given at Different Times After the Administration of 1,2-DiMH on the Induction of r-GT Positive Foci. Rats were given 1,2-DMH.2HCl (100 mg/kg., i.p.) and after 12. 24, 72, or 96 hours they received 5-AzC (10 mg/kg, i.p.). The initiated hepatocytes formed were assayed as described above.
RESULTS AND DISCUSSION
The rationale for using 5-AzC, a n analogue of cytidine, in the present study was based on the fact that its 5 position is not available for methylation (Fig. 2 ), and therefore, when incorporated into DNA it results in creating hypomethylated sites in DNA (14, 15) . Recent studies have demonstrated that methylation of DNA plays a regulatory role in gene function (16, 17) . It was, therefore, of interest to determine whether induction of hypomethylation in DNA would play a role in the initiation process.
The data presented in Table I indicate that 5-AzC given after the administration of 1,2-DMH caused an increase in the incidence of initiated hepatocytes assayed as 7-GT positive foci. Ho\+ever, in the absence of the carcinogen, 1,2-DMH, 5-AzC per se did not induce any initiated hepatocytes. In conformity with our earlier results (2, 6), performing PH following the administration of 1,2-DMH enhanced the induction of initiated hepatocytes. These results clearly suggest that initiation can be achieved not only by supplying the liver with a cell proliferative stimulus such as PH, but also by giving 5-AzC, following the administration of the carcinogen, and are consistent with the hypothesis that generation of hypomethylated DNA following carcinogen treatment potentiates the initiation process. The obvious next question posed was whether the generation of hypomethylated DNA per se is sufficient for initiation or hypornethylation has to occur in specific genomes. When 5-AzC is given following the administration of a non-necrogenic dose of a carcinogen, the analogue will be incorporated in the DNA during the repair process and block the methylation of some cytosines at these sites. On the other hand, when 5-AzC is given after PH the incorporation would be quantitatively greater than during the repair process but would be throughout the genome and not site specific.
The results presented in Table I further indicate that 5-AzC given either 18 or 48 hours after PH did not result in a significant number of initiated hepatocytes. These results are rather interesting and suggest that probably creation of hypomethylation in itself may not be sufficient for initiation, but that it has to be in specific genomes in order to affect initiation. In the present experimental design the site specific incorporation of 5-AzC is probably mediated by the repair process induced by the administered carcinogen. Alternatively, a combination of two lesions, one contributed by the Carcinogen and the second by the generation of hypomethylated DNA may be important for initiation. It is also possible that hypomethylation at more than one site may neutralize their biological effects in such a way that no initiation can be achieved.
The next question was to determine whether both PH and 5-AzC utilize the same critical lesion or use two different critical TOXICOLOGIC PATHOLOGY lesions induced by 1,2-DMH to complete initiation. To answer this question we employed an experimental design wherein PH or 5-AzC were given at different times after the administration of 1,Z-DMH. As pointed out earlier, the rationale was that the longer the interval between the administration of carcinogen and PH or 5-AzC, the greater the repair of the carcinogen-induced critical lesions will be and the number of initiated hepatocytes formed should be fewer. If both PH and 5-AzC should use the same critical lesion(s), one would expect the same pattern in the incidence of initiated hepatocytes.
In our earlier study using 1,2-DMH as the initiating agent and induction of liver cell proliferation by PH as the means to complete initiation, we observed that PH has to be performed before 24 hours following the administration of 1,Z-DMH to achieve initiation (see Table I1 and ref. 5 ). Performing PH 48 hours or later, resulted in a marked decrease in the incidence of initiated hepatocytes. If both 5-AzC and PH utilize the same critical lesion(s), then one should expect a similar pattern in the appearance of initiated hepatocytes when PH or 5-AzC are given at different times after the administration of 1,2-DMH. Interestingly, the data presented in Table I1 clearly indicate that unlike the pattern we observed with PH, the incidence of initiated hepatocytes did not decrease when 5-AzC was given as late as 96 hours after the administration of 1,2-DMH. These results may be interpreted to indicate that the halflife of the lesions induced by 1,2-DMH, critical for initiation by PH, is relatively short compared to that of the lesions that respond to 5-AzC. The results suggest that a single carcinogen may induce more than one critical lesion and the critical nature of the lesion 
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(1 00 m&g) may depend upon how the initiation is completed as with PH or 5-AzC. Using the initiation-promotion models of liver carcinogenesis it is becoming apparent that perhaps carcinogens may induce several critical lesions as a group of primary lesions responsible for initiation and as a grouppf secondary lesions which confer the prop6rty by virtue of which the initiated hepatocytes can be promoted by different promoting regimens. The critical lesions may be different chemically and/or the same, but located at different genomic sites.
